(Q56774465)

Mycobacterium bovis

1 reference

Matthew Peacey

3

0 references

Sarah Gilbert

Sarah C Gilbert

4

0 references

Bryce Buddle

Bryce M Buddle

5

0 references

Sarah Louise Young

1

Sarah L Young

0 references

author name string

Lynn J Slobbe

2

0 references

Geoffrey W de Lisle

6

0 references

Glenn S Buchan

Immunology & Cell Biology

7

0 references

publication date

16 March 2010

0 references

published in

0 references

volume

88

0 references

issue

6

0 references

page(s)

651-657

0 references

cites work

Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.25

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.25

Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.25

Variation in protection by BCG: implications of and for heterologous immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.25

Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.25

Improved immunogenicity of a tuberculosis DNA vaccine encoding ESAT6 by DNA priming and protein boosting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.25

Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.25

A novel DNA vaccine for protective immunity against virulent Mycobacterium bovis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.25

DNA vaccine using Mycobacterium bovis Ag85B antigen induces partial protection against experimental infection in BALB/c mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.25

Interleukin-15 as an Immune Adjuvant To Increase the Efficacy of Mycobacterium bovis Bacillus Calmette-Guérin Vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.25

Prime-boost vaccination based on DNA and protein-loaded microspheres for tuberculosis prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.25

A combined DNA vaccine-prime, BCG-boost strategy results in better protection against Mycobacterium bovis challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.25

Comparison of the protective efficacy of bacille calmette-Guérin vaccination against aerosol challenge with Mycobacterium tuberculosis and Mycobacterium bovis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.25

Pulmonary necrosis resulting from DNA vaccination against tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.25

Enhanced immunogenicity to Mycobacterium tuberculosis by vaccination with an alphavirus plasmid replicon expressing antigen 85A

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.25

Airway delivery of soluble mycobacterial antigens restores protective mucosal immunity by single intramuscular plasmid DNA tuberculosis vaccination: role of proinflammatory signals in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.25

Enhancement of human antigen-specific memory T-cell responses by interleukin-7 may improve accuracy in diagnosing tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.25

Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.25

Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.25

Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.25

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.25

Protective immunity against Mycobacterium tuberculosis induced by dendritic cells pulsed with both CD8(+)- and CD4(+)-T-cell epitopes from antigen 85A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.25

Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.25

Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.25

Oral delivery of Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.25

Improved tuberculosis DNA vaccines by formulation in cationic lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.25

The combination of plasmid interleukin-12 with a single DNA vaccine is more effective than Mycobacterium bovis (bacille Calmette-Guèrin) in protecting against systemic Mycobacterim avium infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.25

7 January 2021

Comparative affects of plasmid-encoded interleukin 12 and interleukin 18 on the protective efficacy of DNA vaccination against Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.25

7 January 2021

Chemokine receptor-mediated delivery of mycobacterial MPT51 protein efficiently induces antigen-specific T-cell responses

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.25

7 January 2021

A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.25

7 January 2021

Improving vaccines against tuberculosis

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.25

7 January 2021

A DNA vaccine encoding MPB83 from Mycobacterium bovis reduces M. bovis dissemination to the kidneys of mice and is expressed in primary cell cultures of the European badger (Meles meles)

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.25

7 January 2021